Aushon Biosystems
25 Adams Street
Suite 1
Burlington
Massachusetts
01803-4910
United States
Tel: 781-750-8664
Fax: 781-750-8733
Website: http://www.aushon.com/
Email: info@aushon.com
43 articles about Aushon Biosystems
-
Aushon Biosystems And ABL, Inc. Announce Adoption Of The Cira Platform For Multiplex And Ultrasensitive Biomarker Testing
9/26/2017
-
Strategic Collaboration Between Aushon Biosystems And RDL Reference Laboratory Announced For Advancing Precision Medicine
7/12/2017
-
Stanley N. Lapidus Joins Aushon Biosystems’s Board Of Directors
5/17/2017
-
Aushon Biosystems Adds Multiplexing To Its Ciraplextm ULTRA Ultrasensitive Assay Product Line With The Launch Of NEW Human Cytokine IL-1ß, IL-6, IL-10 Ultrasensitive 3-Plex Array At The 13th Annual Biomarker And Diagnostic World Congress 2017 In Philadelp
5/2/2017
-
Aushon Biosystems Release: New U.S. Patent Allowance Granted To Company For Microarray Printing Of Complex Biological And Chemical Fluids
1/24/2017
-
Aushon Biosystems Launches New Ciraplex ULTRA Ultrasensitive Assays, Combining The Power Of Multiplexing With Ultrasensitivity, In Conjunction With Pacific Biomarkers Comparative Platform Study Presentation At The 12th Annual Biomarker And Diagnostic Worl
5/17/2016
-
Aushon Biosystems Expands Portfolio Of Ultrasensitive Cira Assays With Additional New Tests
12/15/2015
-
Bruns Grayson Joins Aushon Biosystems Board Of Directors
9/8/2015
-
Aushon Biosystems Announces Availability Of Ultrasensitive Cira Assays
6/2/2015
-
Pacific Biomarkers, Inc. Adopts Aushon Biosystems' Cira Platform for Biomarker Testing
10/3/2013
-
Aushon Biosystems Appoints Industry Veteran Susan Vogt CEO
4/15/2013
-
Aushon Biosystems Appoints Bill Williams Vice President of Sales
11/1/2012
-
Aushon Biosystems and AH Diagnostics Sign Distribution Deal for Scandinavia
11/1/2012
-
Aushon Biosystems Appoints Martin Verhoef Chief Executive Officer
9/5/2012
-
Aushon Biosystems Launches Cira™ Multiplex Protein Biomarker Platform, Achieving ELISA-Level Performance in a Multiplex Format
6/22/2012
-
Aushon Biosystems to Launch New Multiplex Immunoassay Platform
5/22/2012
-
University of Texas MD Anderson Cancer Center Acquires Second Aushon Biosystems' 2470 Microarray Printer for its RPPA Core Facility
7/27/2011
-
Aushon Biosystems' Multiplex Immunoassay Platform Used to Validate Panel of Prognostic and Predictive Protein Biomarkers in Recent Phase II and Phase III Studies
6/10/2011
-
Aushon Biosystems Launches New SignaturePLUS(TM) System for Multiplex Protein Biomarker Analysis
4/5/2011
-
Aushon Biosystems and Peking University Cancer Hospital Collaboration to Focus on Predictive Diagnostic Biomarkers for Liver Metastases of Colorectal Cancer
2/8/2011